BriaCell Therapeutics Corp. Warrant (BCTXW) EPS by Year
BCTXW
BriaCell Therapeutics Corp. Warrant lost $62.19 per diluted share in fiscal year 2025. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters BriaCell Therapeutics Corp. Warrant has filed alongside them.
FY2025 annual
EPS (Diluted)-$62.19
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jan 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
BCTXW EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
More BriaCell Therapeutics Corp. Warrant financials
What was BriaCell Therapeutics Corp. Warrant's diluted earnings per share in fiscal year 2025?
BriaCell Therapeutics Corp. Warrant lost $62.19 per diluted share in fiscal year 2025.
What was BriaCell Therapeutics Corp. Warrant's diluted earnings per share in the most recent quarter?
BriaCell Therapeutics Corp. Warrant (BCTXW) reported -$2.58 in diluted earnings per share in Q2 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what BriaCell Therapeutics Corp. Warrant (BCTXW) reported on that line in every period on record.
